New Zealand markets closed

Precision BioSciences, Inc. (DTIL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.88-0.05 (-0.50%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 68.42M
Enterprise value -38.29M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.72
Price/book (mrq)1.84
Enterprise value/revenue 0.18
Enterprise value/EBITDA -0.27

Trading information

Stock price history

Beta (5Y monthly) 1.73
52-week change 3-44.74%
S&P500 52-week change 320.87%
52-week high 320.25
52-week low 38.25
50-day moving average 311.10
200-day moving average 311.47

Share statistics

Avg vol (3-month) 340k
Avg vol (10-day) 331.49k
Shares outstanding 56.93M
Implied shares outstanding 66.96M
Float 84.76M
% held by insiders 17.08%
% held by institutions 147.04%
Shares short (28 Jun 2024) 4296.93k
Short ratio (28 Jun 2024) 47.27
Short % of float (28 Jun 2024) 44.36%
Short % of shares outstanding (28 Jun 2024) 44.29%
Shares short (prior month 31 May 2024) 4344.8k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 314 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -48.10%
Operating margin (ttm)-23.81%

Management effectiveness

Return on assets (ttm)-11.10%
Return on equity (ttm)-51.66%

Income statement

Revenue (ttm)57.53M
Revenue per share (ttm)13.77
Quarterly revenue growth (yoy)100.30%
Gross profit (ttm)N/A
EBITDA -28.56M
Net income avi to common (ttm)-19.99M
Diluted EPS (ttm)-5.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)137.77M
Total cash per share (mrq)19.89
Total debt (mrq)31.05M
Total debt/equity (mrq)83.46%
Current ratio (mrq)4.82
Book value per share (mrq)5.38

Cash flow statement

Operating cash flow (ttm)-71.63M
Levered free cash flow (ttm)-51.66M